ActoBio Therapeutics

ActoBio Therapeutics Develops Therapeutic Agents for Treating Various Diseases, Focusing on Areas with Unmet Medical NeedsActoBio Therapeutics develops a new class of therapeutic agents called ActoBiotics. These are targeted, microbiome-based, and specifically designed drugs that can locally deliver potentially disease-alleviating therapies to treat a variety of conditions, such as immune-related disorders. ActoBiotics is based on the safe, food-grade bacterium Lactococcus lactis, which is commonly used in cheese and other food production. Engineered Lactococcus lactis is utilized to develop specific therapeutic agents that can be directly delivered to the relevant tissues, enabling treatment across multiple diseases. This approach offers a safer and more effective treatment method compared to injectables.